RELMADA THERAPEUTICS, INC. Accounts Payable and Accrued Liabilities
RELMADA THERAPEUTICS, INC. (RLMD) had Accounts Payable and Accrued Liabilities of $5.57 million as of 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent · last filed 2023-11-08
- 2023-09-30: Accounts Payable and Accrued Liabilities $5.57M.
- 2022-12-31: Accounts Payable and Accrued Liabilities $7.21M.
- 2014-09-30: Accounts Payable and Accrued Liabilities $100.00K.
- 2014-06-30: Accounts Payable and Accrued Liabilities $100.00K.
| Period end | Accounts Payable and Accrued Liabilities |
|---|---|
| 2023-09-30 | $5.57M 10-Q · filed 2023-11-08 |
| 2022-12-31 | $7.21M 10-Q · filed 2023-11-08 |
| 2014-09-30 | $100.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $100.00K 10-K · filed 2015-09-11 |
| 2014-03-31 | $100.00K 8-K · filed 2014-05-27 |
| 2013-12-31 | $100.00K 10-KT · filed 2014-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |